Zhan Ao, Lei Bo, Wu Honggang, Wen YueTao, Zheng Liandong, Wang Shan, Wan Xiaoqiang, Wei Zhenghong
Oncol Res. 2017 May 24;25(5):831-842. doi: 10.3727/096504016X14816726393937. Epub 2016 Dec 15.
Gliomas are the most common and aggressive type of primary adult brain tumors. Although GGNBP2 has previously been considered to be a tumor suppressor gene, little is known about the association between GGNBP2 and glioma. In this study, we clearly demonstrated that GGNBP2 was downexpressed in glioma tissues, and its downexpression is related to the pathological grade and overall survival of patients with gliomas. Overexpression of GGNBP2 suppressed the proliferation, migration, and invasion of glioma cells. Mechanistically, we demonstrated that the PI3K/Akt and Wnt/β-catenin signaling pathways were suppressed by GGNBP2 overexpression. In contrast, knockdown of GGNBP2 has precisely the opposite effect. Collectively, these data indicate that GGNBP2 shows tumor suppressive activity in human glioma cells and may stand out as a potential therapeutic target for glioma.
神经胶质瘤是成人原发性脑肿瘤中最常见且侵袭性最强的类型。尽管GGNBP2此前被认为是一种肿瘤抑制基因,但关于GGNBP2与神经胶质瘤之间的关联却知之甚少。在本研究中,我们明确证实GGNBP2在神经胶质瘤组织中表达下调,其下调与神经胶质瘤患者的病理分级和总生存期相关。GGNBP2的过表达抑制了神经胶质瘤细胞的增殖、迁移和侵袭。从机制上讲,我们证明PI3K/Akt和Wnt/β-连环蛋白信号通路被GGNBP2过表达所抑制。相反,敲低GGNBP2则产生完全相反的效果。总体而言,这些数据表明GGNBP2在人神经胶质瘤细胞中具有肿瘤抑制活性,可能成为神经胶质瘤潜在的治疗靶点。